These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19634346)

  • 1. Why and how to implement a rapid sterility test.
    Gressett G; Vanhaecke E; Moldenhauer J
    PDA J Pharm Sci Technol; 2008; 62(6):429-44. PubMed ID: 19634346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products.
    Parveen S; Kaur S; David SA; Kenney JL; McCormick WM; Gupta RK
    Vaccine; 2011 Oct; 29(45):8012-23. PubMed ID: 21871516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viability-based rapid microbiological methods for sterility testing and the need for identification of contamination.
    Moldenhauer J
    PDA J Pharm Sci Technol; 2006; 60(2):81-8. PubMed ID: 16696190
    [No Abstract]   [Full Text] [Related]  

  • 4. Amendments to sterility test requirements for biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(86):26162-75. PubMed ID: 22606719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an improved sterility test.
    Moldenhauer J; Sutton SV
    PDA J Pharm Sci Technol; 2004; 58(6):284-6. PubMed ID: 15663059
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination.
    Shintani H
    Biocontrol Sci; 2016; 21(2):63-72. PubMed ID: 27350424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical methods for microbiology in the next decade.
    Feldman J
    J Assoc Off Anal Chem; 1982 May; 65(3):535-41. PubMed ID: 7047483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 9. Microbial identification strategies in the pharmaceutical industry.
    Cundell AM
    PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sterility testing of pharmaceuticals.
    Bowman FW
    J Pharm Sci; 1969 Nov; 58(11):1301-8. PubMed ID: 4900221
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid Sterility Test Systems in the Pharmaceutical Industry: Applying a Structured Approach to Their Evaluation, Validation and Global Implementation.
    Deutschmann S; Paul M; Claassen-Willemse M; van den Berg J; IJzerman-Boon P; Grunert da Fonseca V; Brunbech E; Johnson L; Knutsen C; Plourde L; Salvas J; Villari P; Wysocki L
    PDA J Pharm Sci Technol; 2023; 77(3):211-235. PubMed ID: 36697213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bugs Don't Lie.
    Agalloco JP
    PDA J Pharm Sci Technol; 2019; 73(6):615-621. PubMed ID: 31519783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarifications on the Intended Use of USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests.
    Tidswell EC; Tirumalai RS; Gross DD
    PDA J Pharm Sci Technol; 2024 Jun; 78(3):348-357. PubMed ID: 38942475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Milliflex
    Gordon O; Goverde M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2017; 71(3):206-224. PubMed ID: 28196917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current concept for the microbiological safety of cell-based medicinal products].
    Schurig U; Karo JO; Sicker U; Spindler-Raffel E; Häckel L; Spreitzer I; Bekeredjian-Ding I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1225-32. PubMed ID: 26369764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 19. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 20. Activities of the USP Analytical Microbiology Expert Committee during the 2000-2005 revision cycle.
    Sutton SV; Knapp JE; Porter D
    PDA J Pharm Sci Technol; 2005; 59(3):157-76. PubMed ID: 16048116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.